Home > Income Statement > AMBALAL SARABHAI ENTERPRISES

AMBALAL SARABHAI ENTERPRISES
Revenue

    Back to Income Statement
AMBALAL SARABHAI ENTERPRISES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

AMBALAL SARABHAI ENTERPRISES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹196 Cr₹174 Cr₹170 Cr₹197 Cr₹164 Cr

What is the latest Revenue of AMBALAL SARABHAI ENTERPRISES ?

The latest Revenue ratio of AMBALAL SARABHAI ENTERPRISES is ₹196 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹196 Cr
Mar2024₹174 Cr
Mar2023₹170 Cr
Mar2022₹197 Cr
Mar2021₹164 Cr

How is Revenue of AMBALAL SARABHAI ENTERPRISES Trending?

Years Revenue % Change
Mar2025 ₹196 Cr
13.03
Mar2024 ₹174 Cr
1.93
Mar2023 ₹170 Cr
-13.45
Mar2022 ₹197 Cr
20.23
Mar2021 ₹164 Cr -

Compare Revenue of peers of AMBALAL SARABHAI ENTERPRISES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AMBALAL SARABHAI ENTERPRISES ₹210.6 Cr 6% 6% -45.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AMBALAL SARABHAI ENTERPRISES

6%

6%

-45.6%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses